Authors:
Grusch, M
Fritzer-Szekeres, M
Fuhrmann, G
Rosenberger, G
Luxbacher, C
Elford, HL
Smid, K
Peters, GJ
Szekeres, T
Krupitza, G
Citation: M. Grusch et al., Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox, EXP HEMATOL, 29(5), 2001, pp. 623-632
Authors:
Iyamu, WE
Adunyah, SE
Fasold, H
Horiuchi, K
Elford, HL
Asakura, T
Turner, EA
Citation: We. Iyamu et al., Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin, AM J HEMAT, 63(4), 2000, pp. 176-183
Authors:
Fritzer-Szekeres, M
Grusch, M
Luxbacher, C
Horvath, S
Krupitza, G
Elford, HL
Szekeres, T
Citation: M. Fritzer-szekeres et al., Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells, EXP HEMATOL, 28(8), 2000, pp. 924-930
Authors:
Rosenberger, G
Fuhrmann, G
Grusch, M
Fassl, S
Elford, HL
Smid, K
Peters, GJ
Szekeres, T
Krupitza, G
Citation: G. Rosenberger et al., The ribonucleotide reductase-inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells, LIFE SCI, 67(26), 2000, pp. 3131-3142
Authors:
Buller, AM
Elford, HL
DuBois, CC
Meyer, J
Lloyd, JA
Citation: Am. Buller et al., A combination of hydroxyurea and isobutyramide to induce fetal hemoglobin in transgenic mice is more hematotoxic than the individual agents, BL CELL M D, 25(16), 1999, pp. 255-269
Citation: Cn. Mayhew et al., In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activity, STEM CELLS, 17(6), 1999, pp. 345-356